Erratum: System architecture for "support through mobile messaging and digital health technology for diabetes" (SuMMiT-D): Design and performance in pilot and randomized controlled feasibility studies (JMIR Formative Research (2021) 5:3 (e18460) DOI: 10.2196/18460)
Journal article
Chi Y. et al, (2021), JMIR Formative Research, 5
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074
System architecture for "Support through mobile messaging and digital health technology for diabetes" (SuMMiT-D): Design and performance in pilot and randomized controlled feasibility studies
Journal article
Chi Y. et al, (2021), JMIR Formative Research, 5